A 26-Year Follow-up of a Woman With 5 Consecutive Children Exposed to Risperidone During Pregnancy and Breastfeeding

References (10)

1. Damkier P, Videbech P. The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs. 2018;32(4):351–366. PubMed CrossRef
2. Andrade C. Major congenital malformations associated with exposure to second-generation antipsychotic drugs during pregnancy. J Clin Psychiatry. 2021;82(5):21f14252. PubMed CrossRef
3. Andrade C. Gestational and neurodevelopmental outcomes associated with antipsychotic drug exposure during pregnancy. J Clin Psychiatry. 2021;82(5):21f14265. PubMed CrossRef
4. Andrade C. Attention-deficit/hyperactivity disorder, autism spectrum disorder, and other neurodevelopmental outcomes associated with antipsychotic drug exposure during pregnancy. J Clin Psychiatry. 2022;83(3):22f14529. PubMed CrossRef
5. Breadon C, Kulkarni J. An update on medication management of women with schizophrenia in pregnancy. Expert Opin Pharmacother. 2019;20(11):1365–1376. PubMed CrossRef
6. Mendhekar DN, Andrade C. Uneventful use of haloperidol and trihehexyphenidyl during three consecutive pregnancies. Arch Womens Ment Health. 2011;14(1):83–84. PubMed CrossRef
7. Robottom BJ, Reich SG. Exposure to high dosage trihexyphenidyl during pregnancy for treatment of generalized dystonia: case report and literature review. Neurologist. 2011;17(6):340–341. PubMed CrossRef
8. Goyal SK, Goel A. Successful use of risperidone, trihexyphenidyl, and paroxetine in pregnancy. Indian J Psychol Med. 2017;39(6):835–836. PubMed CrossRef
9. Mendhekar D, Lohia D. Risperidone therapy in two successive pregnancies. J Neuropsychiatry Clin Neurosci. 2008;20(4):485–486. PubMed CrossRef
10. Edinoff AN, Silverblatt NS, Vervaeke HE, et al. Hyperprolactinemia, clinical considerations, and infertility in women on antipsychotic medications. Psychopharmacol Bull. 2021;51(2):131–148. PubMed